- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01090297
Continuous Positive Airway Pressure (CPAP) Mode Impact on Clinical Blood Arterial Pressure (AgirSASadom)
CPAP Treatment : Fixed Versus Auto-adjusting Mode Impact on Clinical Blood Arterial Pressure. Randomised, Controlled and Double Blinded Trial in SAOS Patients
Background: Continuous positive airway pressure (CPAP) is the first line therapy for obstructive sleep apnea syndrome (OSAS). Two positive airway pressure (PAP) modalities can be used: Fixed pressure, in which the effective pressure is set and kept constant all night, and auto CPAP devices where the positive pressure changes during the night depend on patient's requirements.
Hypothesis: Pressure variations associated with autoCPAP functioning can lead to sleep fragmentation and alterations in sleep structure. This can limit blood pressure dipping during sleep and then impact clinical blood pressure reduction.
Main objective: To compare in a randomized controlled trial 4 months clinical blood pressure (BP) evolution depending on CPAP mode: fixed pressure versus autoCPAP. Secondary outcomes: Evolution of arterial stiffness, biological parameters, quality of life and symptoms.
Methods: Patients will be randomised depending on CPAP mode. Baseline and 4 months evaluation will include: 24-h ambulatory blood pressure monitoring, clinical BP measurements and carotid-to-femoral pulse wave velocity (PWV). Patients will also complete quality of life and symptoms questionnaires.
2 interim analysis will be carried out when 150 and 220 patients respectively will have completed the study. The Peto's method will be used to correct the p-values.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Meylan, France, 38240
- AGIR à Dom
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- age between 18 and 80 years
- patients who gave written informed consent
- patients who subscribed a social insurance
- SAOS patients who need CPAP treatment.
Exclusion Criteria:
- cardiac failure known and treated
- central Apnea syndrome
- patients who stopped CPAP treatment in the previous year
- pregnant women
- patients under guardianship
- imprisoned patients, patients in hospital
- patients included in an other clinical study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Fixed pressure
|
3 types of Continuous Positive Airway Pressure (CPAP) device: S8 Spirit 2, Somnosmart 2, Remstar Auto. These 3 types of CPAP can be set in both mode of pressure. 3 types of Continuous Positive Airway Pressure (CPAP) device: S8 Spirit 2, Somnosmart 2, Remstar Auto. These 3 types of CPAP can be set in both mode of pressure. 3 types of Continuous Positive Airway Pressure (CPAP) device: S8 Spirit 2, Somnosmart 2, Remstar Auto. These 3 types of CPAP can be set in both mode of pressure. |
Active Comparator: Auto-adjusting pressure
|
3 types of Continuous Positive Airway Pressure (CPAP) device: S8 Spirit 2, Somnosmart 2, Remstar Auto. These 3 types of CPAP can be set in both mode of pressure. 3 types of Continuous Positive Airway Pressure (CPAP) device: S8 Spirit 2, Somnosmart 2, Remstar Auto. These 3 types of CPAP can be set in both mode of pressure. 3 types of Continuous Positive Airway Pressure (CPAP) device: S8 Spirit 2, Somnosmart 2, Remstar Auto. These 3 types of CPAP can be set in both mode of pressure. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Clinical blood pressure
Time Frame: Before treatment, 4 months after treatment
|
Before treatment, 4 months after treatment
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Pulse Wave Velocity
Time Frame: Before treatment, 4 months after treatment
|
Before treatment, 4 months after treatment
|
24 hours Blood Pressure measure
Time Frame: Before treatment, after 4 months of treatment
|
Before treatment, after 4 months of treatment
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AGIR-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obstructive Sleep Apnea Syndrome
-
University of ChicagoGlaxoSmithKlineCompletedChildhood Obstructive Sleep Apnea Syndrome (OSAS)United States
-
University Hospital, GrenobleTerminatedChronic Obstructive Pulmonary Disease (COPD) | Obstructive Sleep Apnea Syndrome (OSAS)France
-
Royal College of Surgeons, IrelandUniversity College Dublin; Connolly Hospital BlanchardstownCompletedObstructive Sleep Apnoea SyndromeIreland
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingModerate Obstructive Sleep Apnea SyndromeFrance
-
Karolinska University HospitalCompletedObstructive Sleep Apnea Syndrome in ChildrenSweden
-
University of Alabama at BirminghamTerminatedObstructive Sleep Apnea Hypopnea Syndrome (OSAHS)United States
-
Sakarya UniversityUnknown
-
Karolinska University HospitalKarolinska InstitutetCompletedObstructive Sleep Apnea SyndromeSweden
-
Haute Ecole de Santé VaudUnknownObstructive Sleep Apnea SyndromeSwitzerland
-
Tyco Healthcare GroupUnknown
Clinical Trials on S8 Spirit 2
-
Associação Fundo de Incentivo à PesquisaUnknownObstructive Sleep Apnea SyndromeBrazil
-
All India Institute of Medical Sciences, New DelhiUnknown
-
Johns Hopkins Bloomberg School of Public HealthInter-Tribal Council of Michigan, Inc.CompletedParenting | Child Development | Mother-Child RelationsUnited States
-
Compumedics LimitedCompletedSleep Apnea, ObstructiveAustralia
-
Johns Hopkins Bloomberg School of Public HealthRecruitingDepressive Symptoms | Substance Use | Anxiety Disorders and Symptoms | Mental Health IssueUnited States
-
Centre Hospitalier Universitaire de Saint EtienneAssociation Lyonnaise de Logistique PosthospitalièreTerminatedAlzheimer Disease | Early Onset Alzheimer Disease | Obstructive Sleep Apnea SyndromesFrance
-
All India Institute of Medical Sciences, New DelhiCompletedMetabolic Syndrome | Obstructive Sleep ApneaIndia
-
Emory UniversityNational Institute on Aging (NIA)Completed
-
Johns Hopkins Bloomberg School of Public HealthCompleted
-
Johns Hopkins UniversitySubstance Abuse and Mental Health Services Administration (SAMHSA); Annie E... and other collaboratorsCompleted